Goldman Sachs Human Evolution ETF
Not enough financial coverage to compute a composite score for GDNA. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Goldman Sachs Human Evolution Index (the "index"). The fund seeks to achieve its investment objective by investing at least 80% of its assets in securities included in its underlying index. The index is designed to deliver exposure to companies with common equity securities listed on exchanges in certain developed markets that may benefit from the development of new knowledge, medicines and technologies for the medical treatment of the human condition, from birth to end-of-life care.
- IPO
- 2019
Price Chart
Performance & Tape
- 52W High
- $68.79
- 52W Low
- $41.71
- 50D MA
- $68.46
- 200D MA
- $64.70
- Beta
- 0.00
- Avg Volume
- 1.40K
Get TickerSpark's AI analysis on GDNA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GDNA Coverage
We haven't published any research on GDNA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GDNA Report →